Clinical Trials Logo

Tumors That Express CA19-9 clinical trials

View clinical trials related to Tumors That Express CA19-9.

Filter by:
  • None
  • Page 1

NCT ID: NCT04883775 Active, not recruiting - Pancreatic Cancer Clinical Trials

Study of a New Technique for Imaging Pancreatic Cancer

Start date: May 10, 2021
Phase: Phase 1
Study type: Interventional

The purpose of this study is to see how well the experimental imaging agent 89Zr-DFO-HuMab-5B1 attaches to pancreatic tumors, and to find out whether PET/CT scans done with this imaging agent produce better images of cancer.

NCT ID: NCT02687230 Terminated - Clinical trials for Pancreatic Carcinoma

Phase 1 Imaging Study of 89Zr-DFO-HuMab-5B1 With HuMab-5B1

Start date: July 11, 2016
Phase: Phase 1
Study type: Interventional

Open label, nonrandomized, dose-escalation trial of MVT-2163 and MVT-5873 used in performing PET scans. The study is designed to determine the best time and dose of these agents that result in the best PET image of a tumor. Subjects will be seen on days 1, 2, 4, and 7 for imaging and a clinical assessment. The last study visit is on day 28.